CoChat

Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II

Open access
Dong, Lan-Feng, Freeman, Ruth, Liu, Ji, Zobalova, Renata, Marin-Hernandez, Alvaro, Stantic, Marina, Rohlena, Jakub, Valis, Karel, Rodriguez-Enriquez, Sara, Butcher, Bevan, Goodwin, Jacob, Brunk, Ulf T., Witting, Paul K., Moreno-Sanchez, Rafael, Scheffler, Immo E., Ralph, Stephen J., Neuzil, Jiri · 2009 · Clinical Cancer Research
Cited by 127

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Purpose: Vitamin E analogues are potent novel anticancer drugs. The purpose of this study was to elucidate the cellular target by which these agents, represented by α-tocopoheryl succinate (α-TOS), suppress tumors in vivo, with the focus on the mitochondrial complex II (CII). Experimental Design: Chinese hamster lung fibroblasts with functional, dysfunctional, and reconstituted CII were transformed using H-Ras. The cells were then used to form xenografts in immunocompromized mice, and response of the cells and the tumors to α-TOS was studied. Results: The CII-functional and CII-reconstituted cells, unlike their CII-dysfunctional counterparts, responded to α-TOS by reactive oxygen species generation and apoptosis execution. Tumors derived from these cell lines reciprocated their responses to α-TOS. Thus, growth of CII-functional and CII-reconstituted tumors was strongly suppressed by the agent, and this was accompanied by high level of apoptosis induction in the tumor cells. On the other hand, α-TOS did not inhibit the CII-dysfuntional tumors. Conclusions: We document in this report a novel paradigm, according to which the mitochondrial CII, which rarely mutates in human neoplasias, is a plausible target for anticancer drugs from the group of vitamin E analogues, providing support for their testing in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-08-2439

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 127

Metadata

Authors
Dong, L.-F., Freeman, R., Liu, J., Zobalova, R., Marin-Hernandez, A., Stantic, M., Rohlena, J., Valis, K., Rodriguez-Enriquez, S., Butcher, B., Goodwin, J., Brunk, U. T., Witting, P. K., Moreno-Sanchez, R., Scheffler, I. E., Ralph, S. J., & Neuzil, J.
Venue
Clinical Cancer Research
Published
2009-02-27
Volume
15
Issue
5
Pages
1593-1600
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W1972871470
Cited by
127
References
11
FWCI
5.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-08-2439
The paper
Dong, L.-F., Freeman, R., Liu, J., Zobalova, R., Marin-Hernandez, A., Stantic, M., Rohlena, J., Valis, K., Rodriguez-Enriquez, S., Butcher, B., Goodwin, J., Brunk, U. T., Witting, P. K., Moreno-Sanchez, R., Scheffler, I. E., Ralph, S. J., & Neuzil, J. (2009). Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-08-2439

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.